| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5665727 | LEO PHARMA AS | Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them |
Sep, 2014
(9 years ago) | |
Protopic is owned by Leo Pharma As.
Protopic contains Tacrolimus.
Protopic has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Protopic are:
- US5665727
Protopic was authorised for market use on 08 December, 2000.
Protopic is available in ointment;topical dosage forms.
Protopic can be used as for the treatment of dermatitis.
The generics of Protopic are possible to be released after 09 September, 2014.
Drugs and Companies using TACROLIMUS ingredient
Market Authorisation Date: 08 December, 2000
Treatment: For the treatment of dermatitis
Dosage: OINTMENT;TOPICAL
How can I launch a generic of PROTOPIC before it's drug patent expiration?
More Information on Dosage
PROTOPIC family patents
